Martin Fehr

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Alexander Eggermont, Christian U. Blank, Mario Mandalà et al. · The Lancet Oncology · 2021 · 389 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

New evidence on the announcement effect of convertible and exchangeable bonds

Manuel Ammann, Martin Fehr, Ralf Seiz · Journal of Multinational Financial Management · 2005 · 71 citations

Business, Economics, Finance +12

Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort

Richard Cathomas, Dirk Klingbiel, T. Geldart et al. · Annals of Oncology · 2014 · 41 citations · Full text

Medicine, Nephrology, Oncology +16

Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience

Caroline Chau, Richard Cathomas, Matthew Wheater et al. · Annals of Oncology · 2015 · 39 citations · Full text

Medicine, Oncology, Surgery +16

Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS

Gerwin Huls, Dana Chiţu, Thomas Pabst et al. · Blood Advances · 2020 · 32 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15